NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 283 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,138,648 | -40.6% | 92,573 | -22.4% | 0.03% | -42.0% |
| Q2 2023 | $1,915,978 | -43.6% | 119,227 | -38.9% | 0.05% | -46.2% |
| Q1 2023 | $3,399,390 | +597.2% | 195,255 | +270.0% | 0.09% | +564.3% |
| Q4 2022 | $487,567 | +95.0% | 52,767 | +82.0% | 0.01% | +55.6% |
| Q3 2022 | $250,000 | -59.5% | 28,989 | +60.2% | 0.01% | -76.3% |
| Q4 2021 | $617,000 | -30.5% | 18,091 | -1.7% | 0.04% | -53.1% |
| Q1 2021 | $888,000 | +181.9% | 18,405 | +214.3% | 0.08% | +145.5% |
| Q4 2020 | $315,000 | -48.0% | 5,856 | -64.4% | 0.03% | -15.4% |
| Q3 2020 | $606,000 | +87.6% | 16,434 | -2.6% | 0.04% | +39.3% |
| Q3 2019 | $323,000 | -67.3% | 16,875 | -65.0% | 0.03% | -60.0% |
| Q1 2019 | $987,000 | +2.9% | 48,248 | -36.6% | 0.07% | +16.7% |
| Q4 2018 | $959,000 | +165.7% | 76,060 | +71.7% | 0.06% | +140.0% |
| Q1 2018 | $361,000 | +102.8% | 44,301 | +96.7% | 0.02% | +8.7% |
| Q1 2017 | $178,000 | +7.2% | 22,520 | +8.8% | 0.02% | +4.5% |
| Q2 2016 | $166,000 | – | 20,696 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |